CME Group/$CME
1D1W1MYTD1Y5YMAX
Capital at risk
About CME Group
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
- Ticker
- $CME
- Sector
- Finance
- Primary listing
- NASDAQ
- Employees
- 3,875
- Headquarters
- Chicago, United States
- Website
- www.cmegroup.com
CME Group Metrics
BasicAdvanced
$98B
23.10
$11.79
0.28
$11.25
1.91%
Price and volume
Market cap
$98B
Beta
0.28
52-week high
$329.16
52-week low
$218.31
Average daily volume
1.8M
Dividend rate
$11.25
Financial strength
Current ratio
1.018
Quick ratio
0.02
Long term debt to equity
0.129
Total debt to equity
0.129
Dividend payout ratio (TTM)
95.08%
Interest coverage (TTM)
25.38%
Profitability
EBITDA (TTM)
4,771.1
Gross margin (TTM)
100.00%
Net profit margin (TTM)
63.44%
Operating margin (TTM)
65.69%
Effective tax rate (TTM)
23.36%
Revenue per employee (TTM)
$1,740,000
Management effectiveness
Return on assets (TTM)
1.48%
Return on equity (TTM)
15.80%
Valuation
Price to earnings (TTM)
23.102
Price to revenue (TTM)
14.506
Price to book
3.69
Price to tangible book (TTM)
-26.88
Price to free cash flow (TTM)
23.272
Free cash flow yield (TTM)
4.30%
Free cash flow per share (TTM)
11.707
Dividend yield (TTM)
4.13%
Forward dividend yield
1.91%
Growth
Revenue change (TTM)
5.04%
Earnings per share change (TTM)
14.17%
3-year revenue growth (CAGR)
8.93%
10-year revenue growth (CAGR)
6.79%
3-year earnings per share growth (CAGR)
12.97%
10-year earnings per share growth (CAGR)
11.53%
3-year dividend per share growth (CAGR)
6.69%
10-year dividend per share growth (CAGR)
1.29%
What the Analysts think about CME Group
Analyst ratings (Buy, Hold, Sell) for CME Group stock.
Analyst projections of the future price of CME Group stock.
Bulls say / Bears say
CME delivered record first-quarter results and a strong second quarter, with first-half revenue up 8% and adjusted EPS up 10%. Momentum continued into July and August, when average daily volume rose 23% and 6% year on year respectively. (Reuters, PR Newswire)
Market data is becoming a stronger, steadier revenue stream: Q2 revenue rose 20% to a record $238 million, extending CME’s run of year-on-year growth. Its margin-efficiency programmes also deepen client ties by helping customers reduce collateral requirements across products. (PR Newswire, CME Group)
The planned Treasury clearing service could open a sizeable new market as firms prepare for the SEC’s central-clearing mandate. Cross-margining cash Treasuries, repo and interest-rate futures could make CME’s venue attractive by lowering clients’ total capital needs. (CME Group)
The latest quarter showed some pressure beneath the strong volume headline: clearing and transaction-fee revenue fell 2.6% year on year, while the average rate per contract declined and expenses increased. This suggests that product mix, pricing or incentives could limit the benefit from higher activity. (24/7 Wall St., SEC filing mirror)
Perpetual futures are a new competitive and regulatory threat, particularly in crypto. If these always-open contracts gain institutional liquidity, they could divert activity from CME’s listed products; CME’s legal challenge also adds uncertainty over how the market will develop. (MarketScreener)
CME relies on a relatively small number of intermediaries: one clearing firm accounted for at least 10% of clearing and transaction fees, while two market-data resellers generated about 25% of data revenue in the first half. Losing or renegotiating with a major counterparty or reseller could therefore affect revenue and pricing power. (Market Inference, SEC filing mirror)
Data summarised monthly by Lightyear AI. Last updated on 16 Sept 2026.
CME Group Financial Performance
Revenues and expenses
CME Group Earnings Performance
Company profitability
Upcoming events
CME Group News
AllArticlesVideos
Funds containing CME Group
AllGBPUSDEUR
Fund name | Fund size | $CME weighting |
|---|---|---|
Invesco CoinShares Global Blockchain£BCHS | £879M | 2.42% |
iShares S&P 500 Financials Sector$IUFS | $2.4B | 1.24% |
iShares S&P 500 Financials Sector£UIFS | £1.8B | 1.24% |
iShares Edge MSCI World Minimum Volatility$MVOL | $2.6B | 0.71% |
iShares Edge MSCI World Minimum Volatility€IQQ0 | €2.3B | 0.71% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.